Azelaic Acid Market Analysis & Forecast: 2026-2033
The global azelaic acid market is expected to grow from USD 236.1 Mn in 2026 to USD 378.9 Mn by 2033, registering a compound annual growth rate (CAGR) of 7% from 2026 to 2033. The global azelaic acid market is driven by expanding use of azelaic acid in pharmaceutical topical creams and prescription formulations. As of September 3, 2025, Merck KGaA expanded the availability of high-purity pharmaceutical-grade azelaic acid for formulation scientists, analytical laboratories, and pharmaceutical developers.
The industrial grade segment is expected to account for 54.0% of the global azelaic acid market share in 2026. Industrial grade azelaic acid has a strong market position, because of its extensive application as an important intermediary in the manufacture of high-performance polymers, plasticizers, synthetic lubricants and specialized coatings. Manufacturers value industrial grade material because it is well-suited for large-scale chemical processing where purity standards differ from medicinal applications, while keeping constant performance characteristics. Rising demand for durable engineering materials, bio-based lubricants, and advanced polymer formulations across automotive, industrial machinery, construction and chemical manufacturing sectors has boosted the consumption of industrial grade azelaic acid, which has, in turn, resulted in producers scaling up the production capacity and optimizing process efficiency. In 2025, Emery’s industrial EMEROX 1144 azelaic acid was certified for use in ecologically suitable lubricant compositions with inclusion on the EU Ecolabel LuSC List. This makes it possible to use azelaic acid in biodegradable industrial lubricants and in lithium complex grease compositions for environmentally sensitive applications.
To learn more about this report, Request Free Sample
The polymer and plasticizer production segment is expected to account for 23.3% of the global azelaic acid market share in 2026. The huge need for high-performance and durable polymer materials in automotive, building, electrical and industrial manufacturing industries is the reason of the widespread usage of azelaic acid in the production of polymers and plasticizers. Azelaic acid is a chemical building ingredient in the production of specialized polyesters and plasticizers. These improve flexibility, thermal stability, chemical resistance and mechanical strength of final materials. The azelaic acid polymer intermediates market is expected to witness a significant growth owing to the increasing demand from the manufacturers for the durable, lightweight, and environment-friendly materials for difficult applications along with increased investments in the sustainable materials and advanced industrial manufacturing technologies. During 2025, Reliance Retail maintained the expansion of Amorepacific brands through its Tira beauty platform, extending the presence of premium Korean skincare labels in key Indian cities through omnichannel retail. The development is proof of the growing appetite for luxury skincare products among India’s premium beauty customers.
The plastics and polymers segment is expected to account for 23.2% of the global azelaic acid market share in 2026. Increasing demand for lightweight, durable and high performance polymer materials in automotive, building, packaging and industrial manufacturing is expected to drive the azelaic acid market in plastics and polymers. Azelaic acid is widely used as a chemical intermediary in the synthesis of specialized polyesters and polymer additives, which improve flexibility, thermal stability, chemical resistance, and overall material performance. The continued adoption of sophisticated engineering plastics and bio-based materials by industries to meet the demand for sustainability and performance is supporting stable expansion in the azelaic acid end-use segment. Manufacturers are increasing the usage of azelaic acid in the production of polymers. On June 17, 2026, BASF and Wacoal announced the extension of their Melooop technology to automotive interior applications based on Elastollan TPU. The collaboration is aimed at lightweight, durable and recyclable polymer components for vehicle armrests and highlights continuous investment in advanced polymer materials.
|
Current Events |
Description and its Impact |
|
European Union - Ecodesign for Sustainable Products Regulation (ESPR) |
|
|
European Union – Packaging and Packaging Waste Regulation (PPWR) |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
To learn more about this report, Request Free Sample
Rising rates of acne, rosacea, melasma and other chronic skin problems is a primary driver of demand for azelaic acid around the globe. Urban pollution, hormonal imbalances, changing lifestyles, longer sun exposure and increasing knowledge of skin health have led to an increasing number of patients seeking effective long-term treatment alternatives. Azelaic acid is commonly prescribed for its antibacterial, anti-inflammatory and skin-brightening qualities, making it ideal for the treatment of several dermatological disorders with relatively excellent tolerance. The growing patient pool is contributing to the steady rise of the worldwide azelaic acid market, with healthcare professionals still focusing on evidence-based topical medicines.
On November 4, 2024, Journey Medical Corporation announced that the U.S. FDA has approved Emrosi (Minocycline Hydrochloride Extended-Release Capsules, 40 mg), formerly DFD-29, for the treatment of inflammatory lesions of rosacea in adults.
Consumers are showing preference towards skin care products that are backed by clinical evidence and recommended by dermatologists. This will lead to increased use of azelaic acid in prescription and OTC formulations. The greater emphasis on ingredient safety, product efficacy and skin compatibility has created a trend toward active substances with scientific support instead of cosmetic claims. Azelaic acid is now widely accepted as a one-stop solution in treating acne, uneven skin tone, post-inflammatory hyperpigmentation and sensitive skin issues. Therefore, the addition of azelaic acid-based products by pharmaceutical and cosmetic manufacturers in their portfolio is expected to drive the growth of the market.
On August 25, 2025, Galderma announced the debut of the first-of-its-kind Cetaphil Nourishing Oil to Foam Cleanser, a solution that deeply cleanses while sustaining hydration and the moisture barrier of sensitive skin. Created with dermatologists and brought to life by a dynamic team of medical specialists and content makers, the cleanser sets the standard for a gentle-but-effective, moisturizing wash.
To learn more about this report, Request Free Sample
Asia Pacific is expected to account for a market share of 40.0% in 2026. Asia Pacific is the leading region for azelaic acid owing to the growth of cosmetic manufacturing, pharmaceutical production and specialty chemical sectors. South Korea and Japan are still leading regional demand through sophisticated dermatological skincare innovation and China has grown to become one of the main manufacturing bases for azelaic acid-based cosmetic ingredients and active pharmaceutical intermediates. India’s pharma sector has stepped up manufacture of topical azelaic acid formulations used for treatment of acne and pigmentation. Glenmark Pharmaceuticals, Sun Pharmaceutical Industries and Ajanta Pharma are among those offering azelaic acid-based treatments.
Japanese cosmetic producers continue to create high-end solutions for sensitive skin and hyperpigmentation, while South Korean beauty firms are increasingly incorporating dermatologist-backed actives into multi-purpose skincare products. Rising e-commerce penetration across China, India, Indonesia, and Southeast Asia has also accelerated the availability of prescription-strength and over-the-counter azelaic acid formulations throughout the region.
North America is projected to account for 21.1% of the global azelaic acid market in 2026 and is expected to register the fastest growth. Widespread doctor prescription, sophisticated pharmaceutical production, and high consumer knowledge of clinically proven skincare ingredients have made North America a major market. The demand in the U.S. is supported by large dermatology clinic networks, significant prescription topical therapy use and a developed cosmeceutical sector. Pharmaceutical businesses are continuing to grow topical treatments in acne vulgaris and rosacea. Cosmetic producers are increasingly launching formulations containing azelaic acid with niacinamide, ceramides and hyaluronic acid for multifunctional skin care. Prescription treatments have also become much more accessible to patients through online pharmacy platforms and direct-to-consumer dermatology services. In Canada, there has also been an increase in the use of dermatologist-recommended skincare products, with customers gravitating towards evidence-based compounds that have proved clinical efficacy.
China has become one of the most prominent countries in the azelaic acid market because of its integrated specialty chemical manufacturing base, fast-growing cosmetics industry and increasing pharmaceutical production capacity. With domestic skincare manufacturers formulating products with clinically validated active ingredients to tackle acne, post-inflammatory hyperpigmentation and sensitive skin issues. China’s competitive specialized chemical producers are continuing to invest in fermentation-based and sustainable chemical manufacturing technologies. Government funding for pharmaceutical research and cosmetic ingredient manufacturing has enhanced the capacity for local production. The fast-growing digital retail platforms like Tmall, JD.com and Douyin have further accelerated consumer access to premium azelaic acid skincare products in urban and lower-tier cities.
The U.S. is a prominent market, driven by a well-developed dermatology sector, significant capabilities in pharmaceutical research and high consumer demand for science-led skincare products. Azelaic acid is routinely given by dermatologists for acne, rosacea and hyperpigmentation and pharmaceutical companies continue to develop superior formulations in gel, foam and cream for topical use. It is seen that more big skincare firms are adding azelaic acid to their arsenal of medical-grade products for sensitive skin and the treatment of post-inflammatory pigmentation. Teledermatology providers and online prescription services have expanded patient access to prescription strength therapies. Meanwhile, clinical research continues to evaluate broader therapeutic possibilities of azelaic acid in inflammatory skin conditions.
Germany is an important European market for azelaic acid given its well‐established pharmaceutical industry, globally competitive chemical production sector, and focus on sustainable specialty chemicals. German companies are still investing in environmentally sound production technologies that are favorable to bio-based chemical intermediates and reduced emission production processes. The demand for pharmaceuticals is stable due to the country’s dermatological clinics and healthcare providers’ use of evidence-based topical therapy for chronic skin conditions. Germany also has a robust cosmetic ingredient supply chain that allows manufacturers to create high-end skincare products that meet the rigorous quality and safety criteria of the European Union.
Ongoing innovation in dermatological healthcare and premium cosmetic formulas continues to make Japan strong. The Japanese consumer market is demanding strongly products for pigmentation, sensitive skin and protection of the skin barrier, which encourages manufacturers to include azelaic acid in sophisticated multifunctional formulations. Domestic pharmaceutical businesses continue to invest in topical drug delivery technologies that give greater efficacy with minimal skin discomfort. The country’s strict quality standards and considerable dermatological research have resulted in highly refined compositions, fit for long-term skincare regimes. The growing demand for clinically proven cosmetic ingredients has further boosted the popularity of azelaic acid among premium skincare brands.
India is a key growth market driven by the expansion of pharmaceutical manufacturing, a higher incidence of acne and pigmentation disorders, and increased consumer awareness of dermatologist-recommended skincare products. Some domestic pharmaceutical businesses including Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Ajanta Pharma and Micro Labs make topical formulation of azelaic acid for domestic and export markets. The fast rise of organized dermatology clinics, online pharmacy platforms and telemedicine services has helped increase access to prescription dermatology treatments across metros and tier-two cities. Additionally, the growing specialized chemical manufacturing in India and government policies to promote local pharmaceutical manufacture are boosting the country’s position in the global azelaic acid value chain.
|
Countries |
Pharmaceutical API demand index (Global Average of 100) |
|
U.S. |
165 |
|
Germany |
145 |
|
Italy |
138 |
|
Japan |
132 |
|
South Korea |
128 |
|
China |
125 |
|
India |
118 |
|
France |
116 |
|
U.K. |
112 |
|
Spain |
108 |
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Advanced drug delivery methods are providing new growth opportunities for azelaic acid, which is traditionally constrained by its relatively poor water solubility, limited skin penetration and propensity for localized irritation at higher dosages. Introduction Pharmaceutical companies and research institutions are now developing liposomal gels, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and polymeric microencapsulation technologies to improve dermal absorption and provide sustained release of the active ingredient.
These innovations are enabling the commercialization of lower-dose formulations that provide similar therapeutic outcomes for acne vulgaris, rosacea, melasma, and post-inflammatory hyperpigmentation with improved patient adherence through less-frequent application and improved tolerability of the skin. Advanced formulation technologies allow the successful combination of azelaic acid with ingredients such as niacinamide, tranexamic acid, ceramides and hyaluronic acid in prescription and dermocosmetic products, opening up premium multifunctional skincare categories and creating new opportunities for pharmaceutical and cosmetic manufacturers to differentiate their product portfolios.
On July 21, 2026, Rohto Pharmaceutical Co., Ltd. announced it will launch the DRX AZA Clear Serum, a serum containing azelaic acid, from its medical-only skincare brand DRX. DRX is a medical-only skincare brand that has focused on the quality and usability required in medical settings.
To learn more about this report, Request Free Sample
The global azelaic acid market is characterized by competition between specialty chemical manufacturers, pharmaceutical ingredient suppliers, and dermatology-focused formulation companies that are strengthening their positions through capacity expansion, sustainable production technologies, and high-purity product development. Emery Oleochemicals continues to lead by utilizing its natural oil-based oleochemical platform to offer bio-based azelaic acid to the industrial market including lubricants, polymers and plasticizers. Matrìca S.p.A. continues its commitment to renewable chemistry with the production of azelaic acid from vegetable feedstocks within its integrated biorefinery in Italy, meeting the European need for sustainable specialty chemicals.
BASF SE is investing in high-performance chemical intermediates and sustainable manufacturing techniques for engineering plastics and industrial applications to increase its market presence. Pharmaceutical raw materials companies including Merck KGaA, Tokyo Chemical Industry (TCI), and Alfa Aesar have an emphasis on offering high-purity research and pharmaceutical-grade azelaic acid for laboratory, formulation, and drug development applications. Chinese manufacturers such as Haihang Industry and Jiangsu Senxuan Pharmaceutical and Chemical are increasing production capacity and improving compliance with international pharmaceutical and cosmetic quality standards to boost export capabilities. Several suppliers are investing in bio-based manufacturing technologies and advanced purification processes to gain a competitive edge in premium markets.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 236.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7% | 2033 Value Projection: | USD 378.9 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Emery Oleochemicals, Matrica S.p.A., BASF SE, Croda International Plc, Haihang Industry Co., Ltd, Tokyo Chemical Industry Co., Ltd. (TCI), Merck KgaA, Otto Chemie Pvt. Ltd., AK Scientific, Inc., Thermo Fisher Scientific, WeylChem International GmbH, Ninghai Zhonglong Chemical Co., Ltd., Jiangsu Senxuan Pharmaceutical, Shandong Hilead Biotechnology Co., Ltd., and Acme Synthetic Chemicals |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Vidyesh Swar is a seasoned Consultant with a diverse background in market research and business consulting. With over 6 years of experience, Vidyesh has established a strong reputation for his proficiency in market estimations, supplier landscape analysis, and market share assessments for tailored research solution. Using his deep industry knowledge and analytical skills, he provides valuable insights and strategic recommendations, enabling clients to make informed decisions and navigate complex business landscapes.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
